Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HTG Molecular Diagnostics Inc HTGMQ

Healthcare Medical Devices
HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and... see more

Recent & Breaking News (GREY:HTGMQ)

HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11

GlobeNewswire August 4, 2022

HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition

GlobeNewswire July 19, 2022

HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility

GlobeNewswire July 18, 2022

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

GlobeNewswire July 6, 2022

Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer

GlobeNewswire June 29, 2022

HTG to Sponsor Keynote Presentation Featuring Customer Use of its HTG EdgeSeq Technology in Clinical Trials

GlobeNewswire June 8, 2022

HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022

GlobeNewswire June 6, 2022

REVISION - HTG to Host Scientific Webinar Featuring Customer Use of the HTG Transcriptome Panel in Preclinical and Clinical Programs

GlobeNewswire June 1, 2022

HTG to Host Scientific Webinar Featuring Customer Use of the HTG Transcriptome Panel in Preclinical and Clinical Programs

GlobeNewswire June 1, 2022

HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference

GlobeNewswire May 17, 2022

HTG Molecular Diagnostics Reports First Quarter 2022 Results

GlobeNewswire May 12, 2022

HTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12

GlobeNewswire May 5, 2022

HTG Expands Therapeutics Team

GlobeNewswire April 13, 2022

HTG Expands Features of Proprietary HTG EdgeSeq Technology

GlobeNewswire April 6, 2022

HTG Releases Proof-of-Approach Whitepaper Establishing Utility of Transcriptome-Informed Approach to Drug Discovery

GlobeNewswire March 31, 2022

HTG Molecular Diagnostics Reports Full Year 2021 Results

GlobeNewswire March 29, 2022

HTG Molecular Diagnostics to Announce Year End 2021 Financial Results and Host Conference Call on Tuesday, March 29

GlobeNewswire March 22, 2022

HTG Molecular Diagnostics Announces $7.5 Million Private Placement

GlobeNewswire March 18, 2022

HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board

GlobeNewswire February 3, 2022

HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors

GlobeNewswire January 28, 2022